4
Changes in Ownership
Compass Therapeutics, Inc. Filed Acc 0001171843-25-003462
CHIEF EXECUTIVE OFFICER bought 10,000 shares at $2.11 ($21,100)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 2025-05-27 | Purchase | +10,000 | $2.11 | $21,100 | 6,480,825 | D |
| Open-market purchases · 10,000 sh · avg $2.11 · $21,100 | |||||||
Loading xslF345X05/ownership.xml…